Safety, Resistance, and Efficacy Results from a Phase IIIb Study of Conventional- and Double-Dose Oseltamivir Regimens for Treatment of Influenza in Immunocompromised Patients

Essack Mitha, Loreta Vareikiene, Gergely Kriván et al.|Infectious Diseases and Therapy|2019

Cited by 26